HRSA Threatens To Fine Drug Makers Over 340B Restrictions

By John Wilkerson / May 17, 2021 at 7:28 PM
The Health Resources and Services Administration threatened to fine drug makers that continue to restrict discounts to hospitals and clinics that dispense 340B drugs through multiple contract pharmacies, and HRSA said drug makers must refund hospitals. However, it’s not clear that the letters that HRSA sent on Monday (May 17) will change drug maker behavior, and the entire thing could land in court with a lot of money on the line, hospital lawyers said. HRSA Acting Administrator Diana Espinosa told...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.